| Crystal Structure of P4502C9 with Flurbiprofen bound | | monomer | 26-490 | 1×HEM; 1×FLP; 1×GOL; |
| Assess |
| Cytochrome 2C9 P450 inhibitor complex | | monomer | 26-489 | 1×XI1; 1×HEM; |
| Assess |
| Design and Optimization of Biaryl Ether Aryl Sulfonamides as Selective Inhibitors of NaV1.7: Discov… | | monomer | 26-489 | 1×HEM; 1×6RJ; |
| Assess |
| Cytochrome 2C9 P450 inhibitor complex | | monomer | 26-489 | 1×HEM; 1×6YF; |
| Assess |
| Crystal structure of CYP2C9 genetic variant A477T (*30) in complex with multiple losartan molecules | | monomer | 28-490 | 1×HEM; 3×LSN; 1×PO4; 1×K; |
| Assess |
| Cytochrome P450 (CYP) 2C9 TCA007 Inhibitor Complex | | monomer | 27-489 | 1×HEM; 1×9W6; 1×GOL; |
| Assess |
| Crystal Structure of the Human Cytochrome P450 2C9*8 (CYP2C9*8) Genetic Variant in Complex with the… | | monomer | 28-490 | 1×HEM; 2×LSN; 1×K; 1×PO4; |
| Assess |
| Crystal structure of CYP2C9 in complex with multiple losartan molecules | | monomer | 28-490 | 3×LSN; 1×HEM; 1×K; |
| Assess |
| Crystal structure of CYP2C9 genetic variant I359L (*3) in complex with multiple losartan molecules | | monomer | 28-490 | 1×HEM; 2×LSN; 1×PO4; 1×K; |
| Assess |
| Crystal Structure of Human P450 2C9*2 Genetic Variant in Complex with Losartan | | monomer | 28-490 | 1×HEM; 1×LSN; |
| Assess |
| Crystal structure of CYP2C9 in complex with an inhibitor | | monomer | 30-490 | 1×HEM; 1×GOL; 1×SO4; 1×2QJ; |
| Assess |
| Structure of human cytochrome P450 CYP2C9 | | monomer | 30-490 | 1×HEC; 1×SWF; |
| Assess |
| Structure of human cytochrome P450 CYP2C9 | | monomer | 30-490 | 1×HEC; |
| Assess |